Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.46 |
| ▸ | LDHB | P07195 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | AGER | Q15109 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7529766 | 0.97 | TDP1 (0.44) | LDHALDHBTDP1ALDH1A1MAPT | |
| SCHEMBL23925923 | 0.87 | THRB (0.43) | LDHALDHBTDP1ALDH1A1MAPT | |
| SCHEMBL2573610 | 0.83 | — | — | |
| SCHEMBL3977216 | 0.81 | — | — | |
| SCHEMBL21410622 | 0.81 | — | — | |
| SCHEMBL16389627 | 0.81 | — | — | |
| SCHEMBL2518142 | 0.81 | — | — | |
| SCHEMBL22382 | 0.67 | ALDH1A1 (0.55) | LDHALDHBTDP1ALDH1A1MAPT | |
| SCHEMBL28726114 | 0.65 | ALDH1A1 (0.52) | LDHALDHBTDP1ALDH1A1MAPT | |
| SCHEMBL23357760 | 0.64 | CYP1A2 (0.48) | TDP1ALDH1A1SMN1; SMN2HSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| US-4123424-A | Polymeric piperazinamides and membranes for reverse osmosis made therefrom | MONTEDISON S.P.A. (IT) | 1978-10-31 | — | — | US | claimed |
| US-4077966-A | Method for the preparation of the monopotassium salt of 1,2,5-thiadiazol-3,4-dicarboxylic acid, and intermediate product | MONTEDISON S.P.A. (IT) | 1978-03-07 | — | — | US | claimed |
| US-4062860-A | FROM DIAMINOMALEONITRILE AND THIONYL CHLORIDE | MONTEDISON S.P.A. (IT) | 1977-12-13 | — | — | US | claimed |
| WO-2026100662-A1 | LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20250348000-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2025-11-13 | — | — | US | disclosed |
| US-20250155813-A1 | PROTECTIVE FILM FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2025-05-15 | — | — | US | disclosed |
| CN-119856108-A | Liquid crystal aligning agent and liquid crystal display element | 日产化学株式会社 | 2025-04-18 | — | — | CN | disclosed |
| WO-2025033304-A1 | METHOD FOR MANUFACTURING LIQUID CRYSTAL ALIGNMENT FILM, AND METHOD FOR MANUFACTURING LIQUID CRYSTAL DISPLAY ELEMENT | 日産化学株式会社 | 2025-02-13 | — | — | WO | disclosed |
| CN-119301526-A | Composition for forming resist underlayer film | 日产化学株式会社 | 2025-01-10 | — | — | CN | disclosed |
| CN-112292633-B | Method for manufacturing zero-face anchor film and liquid crystal display element | 日产化学株式会社 | 2024-11-19 | — | — | CN | disclosed |
| US-4098793-A | Anthraquinone compounds and process for preparing same | MONTEDISON S.P.A. (IT) | 1978-07-04 | — | — | US | disclosed |
| US-4098793-A | Anthraquinone compounds and process for preparing same | MONTEDISON S.P.A. (IT) | 1978-07-04 | — | — | US | disclosed |
| US-4079039-A | POLYBENZIMIDAZOLES, N-HETEROCYCLIC | HORIZONS RESEARCH INCORPORATED (US) | 1978-03-14 | — | — | US | disclosed |
| US-4077966-A | Method for the preparation of the monopotassium salt of 1,2,5-thiadiazol-3,4-dicarboxylic acid, and intermediate product | MONTEDISON S.P.A. (IT) | 1978-03-07 | — | — | US | disclosed |
| US-4077966-A | Method for the preparation of the monopotassium salt of 1,2,5-thiadiazol-3,4-dicarboxylic acid, and intermediate product | MONTEDISON S.P.A. (IT) | 1978-03-07 | — | — | US | disclosed |
| US-4077966-A | Method for the preparation of the monopotassium salt of 1,2,5-thiadiazol-3,4-dicarboxylic acid, and intermediate product | MONTEDISON S.P.A. (IT) | 1978-03-07 | — | — | US | disclosed |
| US-4062860-A | FROM DIAMINOMALEONITRILE AND THIONYL CHLORIDE | MONTEDISON S.P.A. (IT) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | LDHA 163/4885LDHB 325/4885TDP1 3475/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | LDHA 135/4885LDHB 221/4885TDP1 3912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.